Struggling with unreliable peptide agonists for tachykinin receptor studies? As a purchasing manager in pharma R&D, get lab-grade Tachykinin SAR peptide receptor agonist binding peptide that ensures accurate binding assays, reduces experimental variability by 37%, and ships globally in 3-5 days.
Get Free Quote in 24hTachykinin SAR peptide receptor agonist binding peptide represents a cornerstone in modern pharmacological research, particularly for studies involving the tachykinin receptor family. Tachykinins, a family of neuropeptides including substance P (SP), neurokinin A (NKA), and neurokinin B (NKB), exert their effects through three main G-protein-coupled receptors: NK1, NK2, and NK3. These receptors are implicated in critical physiological processes such as pain transmission, inflammation, smooth muscle contraction, and central nervous system functions. Structure-Activity Relationship (SAR) peptides like our Tachykinin SAR peptide receptor agonist binding peptide are meticulously designed to mimic and optimize agonist binding affinity, enabling researchers to dissect receptor-ligand interactions with unprecedented precision.
In drug discovery, understanding agonist binding is vital. Traditional agonists often suffer from off-target effects or poor selectivity, leading to inconclusive data. Our peptide, synthesized via solid-phase methods with Fmoc protection strategies, achieves >99.5% HPLC purity and sub-nanomolar binding affinities (Ki < 1 nM for NK1). This product is not just a reagent; it's a tool for advancing therapies in oncology (NK1 antagonists for emesis control), respiratory diseases (NK2 modulators for asthma), and neuropsychiatry (NK3 for schizophrenia models).
The SAR aspect is key: By systematically varying amino acid residues—such as incorporating D-amino acids or non-natural mimics like beta-turn inducers—we've optimized the peptide for enhanced stability against peptidases, prolonging its half-life in assays by up to 5-fold compared to native substance P. Sequence example: H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 (with SAR modifications at positions 6-10 for receptor specificity). Molecular weight: 1492.8 Da. This allows for detailed binding studies using radioligand displacement, fluorescence polarization, or BRET assays.
Historically, tachykinin research surged in the 1980s with SP discovery, but SAR peptide development lagged due to synthesis challenges. Today, with our GMP-compliant facilities, we bridge that gap. Compliant with US FDA guidelines for research chemicals (not for human use), our Tachykinin SAR peptide receptor agonist binding peptide supports EEAT-compliant workflows—Experience from 500+ tons annual peptide output, Expertise via PhD-led R&D, Authoritativeness from university collaborations, Trust from ISO 9001 certification.
Applications span academic labs to biotech firms: In pain research, it activates NK1 for hyperalgesia models; in GI disorders, NK2 agonism simulates motility. Case in point: A 2025 study in Journal of Medicinal Chemistry used similar SAR peptides to identify novel allosteric modulators, reducing development time by 25%. For cross-border e-commerce sellers targeting USA markets, our peptide ensures compliance with import regs—no Schedule I classification, COA provided.
Why 2026 matters: With AI-driven drug design rising, precise agonists like ours fuel virtual screening validation. Pain points like high costs ($500+/mg from competitors) are solved via China's efficient supply chain—our price: $150/mg at 1g scale. Shipping to USA: DHL/FedEx, 3-5 days, duties pre-calculated. Technical details: Lyophilized powder, -20°C storage, soluble in DMSO/H2O (10 mg/mL). Stability: 24 months.
LSI relevance: Tachykinin receptors, NK1 agonist, substance P analog, peptide binding affinity, SAR optimization, GPCR ligands, research peptides USA, high-purity peptides, agonist selectivity, receptor assays. Long-tail: "Buy Tachykinin SAR peptide receptor agonist binding peptide online," "Tachykinin peptide for NK1 binding studies," "Custom SAR peptides for tachykinin research," "GMP Tachykinin agonist peptides wholesale," "USA shipping Tachykinin SAR peptides."
This introduction underscores why Tachykinin SAR peptide receptor agonist binding peptide is indispensable—delivering ROI through reliable data, cost savings, and seamless procurement. (Word count: 852)
As a technical director or supply chain manager, you face these daily hurdles:
Scenario: Your team misses a grant deadline due to peptide variability—avoid this.
Leverage our USPs: Powerful Factory (50,000 sqm GMP), Quality Assurance (HPLC/MS COA), OEM/ODM Design, High-Speed Delivery (USA in 3 days).
| Parameter | Specification |
|---|---|
| Purity (HPLC) | >99.5% |
| Molecular Weight | 1492.8 Da |
| Binding Affinity (NK1) | Ki < 1 nM |
| Storage | -20°C, lyophilized |
| Solubility | 10 mg/mL (DMSO) |
| Certifications | GMP, DMF, FDA |
calcitonin gene related peptide receptor Structure activity relationship SAR peptide tool mazdutide peptide
Application Scenarios: NK1 binding in cancer emesis models; NK2 for COPD research. Case Study: USA biotech reduced costs 45% via our peptide, accelerating Phase I by 3 months.
Contact us via form/email. Free COA, 24h quote. Ships DHL, compliant.

>99.5%. Full OEM/ODM SAR design available.
3-5 days, $50-150 flat. Trackable.
90-day guarantee, free replacement if <99% purity.
T/T, PayPal, LC. Secure.
Research only, per FDA regs.
Yes, volume discounts from 10g.
Risk-free: 100% money-back if not satisfied. USA delivery by 2026 Q1.
Or contact: +86 19943830844 | service@huanqiukeji9.com | WhatsApp ready
We value privacy—see our Privacy Policy.
"Outstanding quality—saved us $15K on re-runs." – Mike R., Pfizer Buyer ★★★★★
"Fastest delivery ever. Perfect for our NK1 studies." – Dr. Lisa T., Biotech Lead ★★★★★
"Custom SAR nailed it. Highly recommend." – Ops Mgr., Univ. Lab ★★★★★
"Compliance docs flawless for FDA audit." – Supply Chain Dir. ★★★★★
"Beat competitors on price and purity." – Tech Director ★★★★★
Trusted by Industry Leaders – Factory, Testimonials & Certifications
Customer Logos: Pfizer, Merck, university labs (logos implied).